Quarterly report · Q2
2914.TEDINET S100OWUD
Period2022-01-01 → 2022-06-30
Filed2022-08-08
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Amends S100OTFM.
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.27T | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥685.3bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥2.32T | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.14T | 2021-01-01 → 2021-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥597.2bn | 2021-04-01 → 2021-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥383.0bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥204.6bn | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥322.1bn | 2021-01-01 → 2021-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥162.0bn | 2021-04-01 → 2021-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥361.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥186.3bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥472.4bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥314.1bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥157.8bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥264.1bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥140.0bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥338.5bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥225.2bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥111.4bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥265.0bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥140.4bn | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Net income | ¥340.2bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥225.9bn | 2021-01-01 → 2021-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥111.9bn | 2021-04-01 → 2021-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.65T | at 2022-06-30 | Cons. | Assets IFRS |
| Total assets | ¥5.77T | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥5.54T | at 2021-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥2.89T | at 2022-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥2.89T | at 2021-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥3.75T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.89T | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.86T | at 2021-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.60T | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.68T | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.81T | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥748.7bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥721.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥480.7bn | at 2021-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥538.8bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥110.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥598.9bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥174.9bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥38.8bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥97.5bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥46.5bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥158.2bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥353.1bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥212.7bn | 2021-01-01 → 2021-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥148.8 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥78.86 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥190.76 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥126.92 | 2021-01-01 → 2021-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥62.78 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥148.74 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥78.83 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥190.68 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥126.86 | 2021-01-01 → 2021-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥62.76 | 2021-04-01 → 2021-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 55.3% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 48.6% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 50.3% | at 2021-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 136
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-06-30 | ¥7.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥5.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-06-30 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥496m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-06-30 | −¥12.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥9.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | −¥4.8bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-06-30 | −¥6.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥5.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥10m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥39.3bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥18.0bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥299m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥73.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥37.8bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥416m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥99m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥629.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.15T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥629.0bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥425.1bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥390.3bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥227.8bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥209.0bn |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥684.9bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥1.27T |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥684.8bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-06-30 | ¥138m |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥79m |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥431.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥395.6bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥229.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥209.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-01-01 → 2021-06-30 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-01-01 → 2021-06-30 | ¥898m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-06-30 | ¥565m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥1.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | −¥19.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | −¥19.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-01-01 → 2021-06-30 | −¥19.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥10.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥10.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-06-30 | −¥10.8bn |
| Reconciling Itemsreconciling | revenue | 2021-01-01 → 2021-06-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-01-01 → 2021-06-30 | −¥2.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥54m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥54m |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-06-30 | −¥54m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥26m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥37.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥37.1bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥3.8bn |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥672m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥672m |
| jpcrp040300-q2r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2021-04-01 → 2021-06-30 | −¥472m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥70.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥36.7bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥70.4bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥36.7bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥469m |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.1bn |
| jpcrp040300-q2r_E00492-000Processed Foodreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2021-01-01 → 2021-06-30 | ¥1.04T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥542.6bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2021-01-01 → 2021-06-30 | ¥1.04T |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥542.6bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥149m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥86m |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥372.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥372.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-01-01 → 2021-06-30 | ¥337.7bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥190.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥190.4bn |
| jpcrp040300-q2r_E00492-000Tobaccoreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥172.1bn |
| —segment total | revenue | 2021-01-01 → 2021-06-30 | ¥1.14T |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥596.7bn |
| —segment total | revenue external | 2021-01-01 → 2021-06-30 | ¥1.14T |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥596.6bn |
| —segment total | revenue intersegment | 2021-01-01 → 2021-06-30 | ¥149m |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥86m |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥377.7bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥377.7bn |
| —segment total | segment profit | 2021-01-01 → 2021-06-30 | ¥341.9bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥190.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥190.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥172.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,136
| Item | Context | Value | Unit |
|---|---|---|---|
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 26130000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 113771000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 480706000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 748696000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 1036144000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 37051000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 70446000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 1143641000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 898000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration | 1144539000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 149000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 0 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 149000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2626000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -2775000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration | － | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 1036293000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 37051000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 70446000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 1143790000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3524000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -2775000000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 1144539000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 372689000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 3556000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 1453000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_ReportableSegmentsMember | 377697000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -19420000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration_ReconcilingItemsMember | -54000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration | 358223000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 1152960000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 39300000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 73461000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_ReportableSegmentsMember | 1265721000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1107000000 | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | CurrentYTDDuration | 1266828000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 138000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 0 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 138000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6209000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -6347000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration | － | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000TobaccoReportableSegmentMember | 1153098000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000PharmaceuticalsReportableSegmentMember | 39300000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00492-000ProcessedFoodReportableSegmentMember | 73461000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReportableSegmentsMember | 1265859000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |